Stocksigma LogoStocksigma Logo

Ind-Swift Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 24,046 (+51.6% YoY | +25.6% QoQ) ■ EBITDA: 4,546 (+508.5% YoY | +36.0% QoQ) ■ EBITDA Margin (%): 18.9 (+1420 bps YoY | +144 bps QoQ) ■ PAT

Ind-Swift Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Ind-Swift Laboratories Ltd · Outcome · 29 Oct 2026, 8:29 pm

Ind-Swift Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 24,046 (+51.6% YoY | +25.6% QoQ) ■ EBITDA: 4,546 (+508.5% YoY | +36.0% QoQ) ■ EBITDA Margin (%): 18.9 (+1420 bps YoY | +144 bps QoQ) ■ PAT: 3,422 (+328.3% YoY | +38.6% QoQ) ■ EPS (INR): 3.92 (+308.3% YoY | +38.0% QoQ)

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements